Abstract
Traumatic brain injury (TBI) is a major public health issue in the USA, with over 1.7 million cases per year. At least 5.3 million Americans currently live with ongoing disability due to TBI (Walker and Tesco 2013). The long-term consequences of TBI can be complex and progressive: 10–15% of individuals diagnosed with mild TBI continue to suffer from persistent symptoms, while as many as 50% of patients with moderate TBI experience long-term dysfunction (Bales et al. 2009; Walker and Tesco 2013). In addition to the post-injury development of cognitive deficits in attention, memory, and executive function (Bales et al. 2009), a chronic inflammatory state can persist in the brain for months, and even years, following TBI (Opii et al. 2007; Piao et al. 2013). Despite the prevalence of these chronic dysfunctions following TBI, elucidating the mechanisms that underlie these symptoms has proven challenging. It is understood that the post-injury processes of TBI involve a primary and a secondary phase of injury. Primary injury occurs during the initial insult, resulting from the displacement of the physical structures within the brain. Secondary injury occurs over time and involves an interdependent series of cellular dysfunctions that persist long after injury (Giza and Hovda 2001; Nilsson et al. 1996; Park et al. 2008; Walker and Tesco 2013; Werner and Engelhard 2007). Currently, it is not well understood how the acute mechanical injury of TBI, and subsequent secondary injury processes, can result in serious long-term dysfunctions that can persist for years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ATP:
-
Adenosine triphosphate
- C:
-
Control
- Ca2+ :
-
Calcium
- CCI:
-
Controlled cortical impact
- GFAP:
-
Glial fibrillary acidic protein
- kDa:
-
Kilodalton
- mAb:
-
Monoclonal anti-citrulline antibody
- MBP:
-
Myelin basic protein
- MS:
-
Multiple sclerosis
- NMDA:
-
N-methyl-d-aspartate
- PAD:
-
Peptidylarginine deiminase
- TBI:
-
Traumatic brain injury
References
Acharya, N. K., Nagele, E. P., Han, M., Coretti, N. J., DeMarshall, C., Kosciuk, M. C., et al. (2012). Neuronal PAD4 expression and protein citrullination: Possible role in production of autoantibodies associated with neurodegenerative disease. Journal of Autoimmunity, 38, 369–380.
Adamus, G., Bonnah, R., Brown, L., & David, L. (2013). Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy. BMC Ophthalmology, 13, 48.
Anderton, S. M. (2004). Post-translational modifications of self antigens: Implications for autoimmunity. Current Opinion in Immunology, 16(6), 753–758.
Anzilotti, C., Pratesi, F., Tommasi, C., & Migliorini, P. (2010). Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmunity Reviews, 9(3), 158–160.
Asaga, H., & Ishigami, A. (2001). Protein deimination in the rat brain after kainate administration: Citrulline-containing proteins as a novel marker of neurodegeneration. Neuroscience Letters, 299, 5–8.
Bales, J. W., Wagner, A. K., Kline, A. E., & Dixon, C. E. (2009). Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neuroscience and Biobehavioral Reviews, 33(7), 981–1003.
Berry, C., Ley, E. J., Tillou, A., Cryer, G., Marguilies, D. R., & Salim, A. (2009). The effect of gender on patients with moderate to severe head injuries. Journal of Trauma – Injury, Infection &. Critical Care, 67(5), 950–953.
Bhattacharya, S. K., Crabb, J. S., Bonilha, V. L., Gu, X., Takahara, H., & Crabb, J. W. (2006). Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Investigative Ophthalmology & Visual Science, 47(6), 2508–2514.
Bradford, C., Nicholas, A. P., Woodroofe, N., & Cross, A. K. (2002). Chapter 10: Deimination in multiple sclerosis and experimental autoimmune encephalomyelitis. In A. Nicholas & S. Bhattacharya (Eds.), Protein deimination in human health and disease (pp. 165–185). New York: Springer.
Bradford, C. M., Ramos, I., Cross, A. K., Haddock, A. K., McQuaid, S., Nicholas, A. P., & Woodroofe, M. N. (2014). Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis. Journal of Neuroimmunology, 273(1–2), 85–95.
Chirivi, R. G. S., van Rosmalen, J. W. G., Jenniskens, G. J., Pruijn, G. J., & Raats, J. M. H. (2013). Citrullination: A target for disease intervention in multiple sclerosis and other inflammatory diseases? Journal of Clinical and Cellular Immunology, 4, 146. doi:10.4172/2155-9899.1000146.
Chung, Y. H., Shin, C. M., Kim, M. J., & Cha, C. I. (2001). Enhanced expression of L-type Ca2+ channels in reactive astrocytes after ischemic injury in rats. Neuroscience Letters, 302, 93–96.
Curis, E., Nicolis, I., Moinard, C., Osowska, S., Zerrouk, N., Bénazeth, S., & Cynober, L. (2005). Almost all about citrulline in mammals. Amino Acids, 29(3), 177–205.
Dalle-Donne, I., Aldini, G., Carini, M., Colombo, R., Rossi, R., & Milzani, A. (2006). Protein carbonylation, cellular dysfunction, and disease progression. Journal of Cellular and Molecular Medicine, 10(2), 389–406.
Duffy, S., & MacVicar, B. A. (1996). In vitro ischemia promotes calcium influx and intracellular calcium release in hippocampal astrocytes. The Journal of Neuroscience, 16(1), 71–81.
Fineman, I., Hovda, D. A., Smith, M., Yoshino, A., & Becker, D. P. (1993). Concussive brain injury is associated with a prolonged accumulation of calcium: A 45Ca autoradiographic study. Brain Research, 624, 94–102.
Floyd, C. L., Gorin, F. A., & Lyeth, B. G. (2005). Mechanical strain injury increases intracellular sodium and reverses Na+/Ca2+ exchange in cortical astrocytes. Glia, 51(1), 35–46.
Giza, C. C., & Hovda, D. A. (2001). The neurometabolic cascade of concussion. Journal of Athletic Training, 36(3), 228–235.
Goswasser, Z., Cohen, M., & Keren, O. (1998). Female TBI patients recover better than males. Brain Injury, 12, 805–808.
Gould, R. M., Freund, C. M., Palmer, F., & Feinstein, D. L. (2000). Messenger RNAs located in myelin sheath assembly sites. Journal of Neurochemistry, 75(5), 1834–1844.
György, B., Tóth, E., Tarcsa, E., Falus, A., & Buzás, E. I. (2006). Citrullination: A posttranslational modification in health and disease. The International Journal of Biochemistry & Cell Biology, 38, 1662–1677.
Haun, S. E., Murphy, E. J., Bates, C. M., & Horrocks, L. A. (1992). Extracellular calcium is a mediator of astroglial injury during combined glucose-oxygen deprivation. Brain Research, 593, 45–50.
Hensvold, A. H., Reynisdottir, G., & Catrin, A. I. (2002). Chapter 2: From citrullination to specific immunity and disease in rheumatoid arthritis. In A. Nicholas & S. Bhattacharya (Eds.), Protein deimination in human health and disease (pp. 25–40). New York: Springer.
Ishigami, A., & Maruyama, N. (2010). Importance of research on peptidylarginine deiminase and citrullinated proteins in age-related disease. Geriatrics & Gerontology International, 10(Suppl 1), S53–S58.
Ishigami, A., Ohsawa, T., Hiratsuka, M., Taguchi, H., Kobayashi, S., Saito, Y., et al. (2005). Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer’s disease. Journal of Neuroscience Research, 80(1), 120–128.
Jang, B., Kim, E., Choi, J. K., Jin, J. K., Kim, J. I., Ishigami, A., et al. (2008). Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice. The American Journal of Pathology, 173(4), 1129–1142.
Jang, B., Shin, H. Y., Choi, J. K., Nguyen du, P. T., Jeong, B. H., Ishigami, A., et al. (2011). Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: Nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins. Journal of Neuropathology and Experimental Neurology, 70(2), 116–124.
Kinloch, A., Tatzer, V., Wait, R., Peston, D., Lundberg, K., Donatien, P., et al. (2005a). Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Research & Therapy, 7, R1421–R1429.
Kinloch, A., Tatzer, V., Wait, R., Peston, D., Lundberg, K., Donatien, P., et al. (2005b). Identification of citrullinated α-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Research & Therapy, 7(6), R1421–R1429.
Lam, G. (2006). Round 4: Citrullinated proteins, peptidylarginine deiminase (PAD), and rheumatoid arthritis. Baltimore, MD: Johns Hopkins, Arthritis Center.
Lange, S., Rocha-Ferreira, E., Thei, L., Mawjee, P., Bennett, K., Thompson, P. R., et al. (2014). Peptidylarginine deiminases: Novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates. Journal of Neurochemistry, 130(4), 555–562.
Lazarus, R. C. (2015). Protein modification: A proposed mechanism for the long-term pathogenesis of traumatic brain injury. Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814. Retrieved from http://cdm16005.contentdm.oclc.org/cdm/ref/collection/p15459coll1/id/117618
Lazarus Rachel, C., Buonora John, E., Flora Michael, N., Freedy James, G., Holstein Gay, R., Martinelli Giorgio, P., Jacobowitz David, M., & Mueller Gregory, P. (2015). Protein citrullination: A proposed mechanism for pathology in traumatic brain injury. Frontiers in Neurology, 6, 204. doi:10.3389/fneur.2015.00204.
Lazarus, R. C., Buonora, J. E., Jacobowitz, D. M., & Mueller, G. P. (2015). Protein carbonylation after traumatic brain injury: Cell specificity, regional susceptibility, and gender differences. Free Radical Biology and Medicine, 78, 89–100.
McIntosh, T. K., Saatman, K. E., & Raghupathi, R. (1997). Calcium and the pathogenesis of traumatic CNS injury: Cellular and molecular mechanisms. The Neuroscientist, 3(3), 169–175.
Murinson, B. B., & Guarnaccia, J. B. (2008). Stiff-person syndrome with amphiphysin antibodies: Distinctive features of a rare disease. Neurology, 71(24), 1955–1958.
Musse, A. A., Li, Z., Ackerly, C. A., Bienzle, D., Lei, H., Poma, R., et al. (2008). Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Disease Models & Mechanisms, 1(4), 229–240.
Nicholas, A. P. (2010). Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra. Neuroscience Letters, 495, 26–29.
Nicholas, A. P., Sambandam, T., Echols, J. D., & Tourtellotte, W. W. (2004). Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. The Journal of Comparative Neurology, 473(1), 128–136.
Nicholas, A. P., Sambandam, T., Echols, J. D., & Barnum, S. R. (2005). Expression of Citrullinated proteins in murine experimental autoimmune encephalomyelitis. The Journal of Comparative Neurology, 486, 254–266.
Nilsson, P., Laursen, H., Hillered, L., & Hansen, A. J. (1996). Calcium movements in traumatic brain injury: The role of glutamate receptor-operated ion channels. Journal of Cerebral Blood Flow & Metabolism, 16, 262–270.
Okonkwo, D. O., Yue, J. K., Puccio, A. M., Panczykowski, D. M., Inoue, T., McMahon, P. J., et al. (2013). GFAP-BDP as an acute diagnostic marker in traumatic brain injury: Results from the prospective transforming research and clinical knowledge in traumatic brain injury study. Journal of Neurotrauma, 30(17), 1490–1497.
Opii, W. O., Nukal, V. N., Sultana, R., Pandya, J. D., Day, K. M., Marchant, M. L., et al. (2007). Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. Journal of Neurotrauma, 24(5), 772–789.
Park, E., Bell, J. D., & Baker, A. J. (2008). Traumatic brain injury: Can the consequences be stopped? CMAJ, 178(9), 1163–1170.
Piao, C. S., Stoica, B. A., Wu, J., Sabirzhanov, B., Zhao, Z., Cabatbat, R., et al. (2013). Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury. Neurobiology of Disease, 46(3), 745–758.
Raijmakers, R., Vogelzangs, J., Croxford, J. L., Wesseling, P., van Venrooij, W. J., & Pruijn, G. J. (2005). Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis. The Journal of Comparative Neurology, 486(3), 243–253.
Ray, S. K., Dixon, C. E., & Banik, N. L. (2002). Molecular mechanisms in the pathogenesis of traumatic brain injury. Histology and Histopathology, 17, 1137–1152.
Rolls, A., Shechter, R., & Schwartz, M. (2009). The bright side of the glial scar in CNS repair. Nature Reviews Neuroscience, 10, 235–241.
Rondas, D., Crèvecoeur, I., D’Hertog, W., Ferreira, G. B., Staes, A., Garg, A. D., et al. (2014). Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes. Diabetes, 64(2), 573–586.
Roof, R. L., Hoffamn, S. W., & Stein, D. G. (1997). Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Molecular and Clinical Neuropathology, 31(1), 1–11.
Rorhbach, A. S., Arandjelovic, S., & Mowen, K. A. (2002). Physiological pathways of PAD activation and citrullinated epitope generation. In A. Nicholas & S. Bhattacharya (Eds.), Protein deimination in human health and disease (pp. 1–24). New York: Springer.
Rzigalinski, B. A., Weber, J. T., Willoughby, K. A., & Ellis, E. F. (1998). Intracellular free calcium dynamics in stretch-injured astrocytes. Journal of Neurochemistry, 70(6), 2377–2385.
Spengler, J., & Schell-Toellner, D. (2014). Neutrophils and their contributions to autoimmunity in rheumatoid arthritis. In A. Nicholas & S. Bhattacharya (Eds.), Protein deimination in human health and disease (pp. 97–111). New York: Springer.
Sun, D. A., Deshpande, L. S., Sombati, S., Baranova, A., Wilson, M. S., Hamm, R. J., & DeLorenzo, R. J. (2008). Traumatic brain injury causes a long-lasting calcium (Ca2+)-plateau of elevated intracellular Ca levels and altered Ca2+ homeostatic mechanisms in hippocampal neurons surviving brain injury. The European Journal of Neuroscience, 27(7), 1659–1672.
Szydlowskaa, K., & Tymianskia, M. (2010). Calcium, ischemia and excitotoxicity. Cell Calcium, 47(2), 122–129.
Tranquill, L. R., Cao, L., Ling, N., Kalbacher, H., Martin, R. M., & Whitaker, J. N. (2000). Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients. Multiple Sclerosis, 6, 220–225.
Vossenaar, E. R., Radstake, T. R. D., van der Heijden, A., van Mansum, M. A. M., Dieteren, C., de Rooij, D. J., et al. (2004). Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Annals of the Rheumatic Diseases, 63, 373–381.
Walker, K. R., & Tesco, G. (2013). Molecular mechanisms of cognitive dysfunction following traumatic brain injury. Frontiers in Aging Neuroscience, 5, 29.
Wang, S., & Wang, Y. (2013). Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochimica et Biophysica Acta, 1829, 1126–1135.
Weber, J. T. (2012). Altered calcium signaling following traumatic brain injury. Frontiers in Pharmacology, 3(60), 1–16.
Werner, C., & Engelhard, K. (2007). Pathophysiology of traumatic brain injury. British Journal of Anaesthesia, 99(1), 4–9.
Zhang, Z., Zoltewicz, J. S., Mondello, S., Newsom, K. J., Yang, Z., Yang, B., et al. (2014). Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products. PloS One, 9(3), e92698.
Zhao, Y., Tian, X., & Li, Z. G. (2010). Impact of citrullination upon antigenicity of fibrinogen. Zhonghua Yi Xue Za Zhi, 90(9), 628–632.
Zoltewicz, J. S., Scharf, D., Yang, B., Chawla, A., Newsom, K. J., & Fang, L. (2012). Characterization of antibodies that detect human GFAP after traumatic brain injury. Biomarker Insights, 7, 71–79.
Acknowledgments
Support for this work included a grant from the Defense Medical Research and Development Program (D61_I_10_J6_152) and Department of Defense in the Center for Neuroscience and Regenerative Medicine (G1703D) as well as funding from the Uniformed Services University of the Health Sciences (T0702554 and R07028414).
Disclosure
Some of the findings presented here have appeared in publication (Lazarus Rachel et al. 2015) and in a PhD dissertation (RCL) which is available by public access at http://cdm16005.contentdm.oclc.org/cdm/ref/collection/p15459coll1/id/117618 (Lazarus 2015).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Lazarus, R.C. et al. (2017). Citrullination Following Traumatic Brain Injury: A Mechanism for Ongoing Pathology Through Protein Modification. In: Nicholas, A., Bhattacharya, S., Thompson, P. (eds) Protein Deimination in Human Health and Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-58244-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-58244-3_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58243-6
Online ISBN: 978-3-319-58244-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)